Prescient Drug Delivery Consultants (PDDC) specializes in enhancing small molecule translational drug discovery programs through a range of expert consultation services. Their mission encompasses improving the biopharmaceutical and physico-chemical attributes of drug candidates, developing formulations for various preclinical studies, and critically assessing the likelihood of success for drug candidate developability. PDDC also focuses on implementing advanced drug delivery technologies, enhancing intellectual property profiles, and facilitating accelerated clinical entry through adaptive formulation strategies. Their extensive experience, totaling over 80 years, allows them to address complex challenges related to drug delivery, stability, metabolism, safety, and toxicity.

In addition to their consultation services, PDDC offers tailored support based on the specific needs of their clients. They can provide advisory roles for study design and execution in collaboration with preferred Contract Research Organizations (CROs) or work directly alongside client scientists in their laboratories. This flexibility in structuring consultations ensures that PDDC can effectively meet the diverse requirements of academic, government, and biotech partners, ultimately striving to enhance the success of therapeutic entities in development.

United States

We bring an aggregate 80+ years of diverse experience in solving complex issues with preclinical drug candidates by identifying creative and innovative solutions for key problems with drug delivery, exposure, chemical and physical stability, drug metabolism, safety, and toxicity. IP expert witness.

Prescient Drug Discovery Consultants

Company Details